In the unlikely event that none of the four siRNA duplexes efficiently silences the target gene, the company will design and synthesise four free replacement duplexes
Qiagen continues to expand its range of products and services for RNAi applications.
New 4-for-Silencing siRNA duplexes consist of four siRNA duplexes, custom designed by Qiagen to efficiently target a gene of choice.
Qiagen guarantees that at least one duplex will provide at least 70% knockdown of gene expression. The efficiency of gene silencing with a single given siRNA is not fully predictable, and there is a risk that a particular siRNA will not result in effective silencing.
4-for-Silencing siRNA duplexes minimise this risk to provide guaranteed, efficient gene silencing.
In the unlikely event that none of the four siRNA duplexes efficiently silences the target gene, Qiagen will design and synthesise four free replacement duplexes.
4-for-Silencing siRNA duplexes are designed by experienced scientists using state-of-the-art criteria.
Qiagen provides full sequence information upon delivery of the siRNA at no extra cost.
There are no restrictions on publication of the sequences, and complete confidentiality is guaranteed.
Researchers simply provide information about their target gene, preferably as RefSeq entries, although other formats are also acceptable.
After synthesis, Qiagen delivers each siRNA in separate vials containing 20nmol of high performance purity (HPP) grade siRNA. HPP grade siRNA is >90% pure, and thorough quality control checks are performed, ensuring that 4-for-Silencing siRNA duplexes deliver the quality, value, and performance that RNAi research demands.
